NEW YORK ( TheStreet) -- Hospira (NYSE: HSP) hit a new 52-week low Wednesday as it is currently trading at $29.06, below its previous 52-week low of $34.18 with 1.1 million shares traded as of 10 a.m. ET. Average volume has been 1.5 million shares over the past 30 days.

Hospira has a market cap of $6.2 billion and is part of the health care sector and drugs industry. Shares are down 47% year to date as of the close of trading on Tuesday.

Hospira, Inc., a specialty pharmaceutical and medication delivery company, that develops, manufactures, and markets products that help improve the safety and productivity of patient care. The company has a P/E ratio of 17.5, above the average drugs industry P/E ratio of 14.9 and below the S&P 500 P/E ratio of 17.7.
  • Practice your HSP trading strategies and win cash in our stock game.

TheStreet Ratings rates Hospira as a hold. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and disappointing return on equity. You can view the full Hospira Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.